{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T15:44:00Z","timestamp":1758815040787},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010449","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Federal Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","ejinme.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejim.2017.08.011","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T17:15:44Z","timestamp":1503076544000},"page":"62-68","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Medication use in long-term survivors from the MONICA\/KORA Myocardial Infarction Registry"],"prefix":"10.1016","volume":"47","author":[{"given":"Ute","family":"Amann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Kirchberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margit","family":"Heier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Thilo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Kuch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christa","family":"Meisinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.08.011_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","volume":"37","author":"Roffi","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.08.011_bb0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1093\/eurheartj\/ehs215","article-title":"ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation","volume":"33","author":"Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC)","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.08.011_bb0015","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.08.011_bb0020","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjcard.2011.08.024","article-title":"Effect of use of combination evidence-based medical therapy after acute coronary syndromes on long-term outcomes","volume":"109","author":"Lahoud","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0025","first-page":"655","article-title":"Long-term survival in patients with different combinations of evidence-based medications after incident acute myocardial infarction: results from the MONICA\/KORA Myocardial Infarction Registry","volume":"103","author":"Amann","year":"2014","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0030","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jacc.2015.07.018","article-title":"Long-term use of cardiovascular drugs: challenges for research and for patient care","volume":"66","author":"Rossello","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0035","doi-asserted-by":"crossref","first-page":"247","DOI":"10.18553\/jmcp.2013.19.3.247","article-title":"Adherence to evidence-based therapies after acute coronary syndrome: a retrospective population-based cohort study linking hospital, outpatient, and pharmacy health information systems in Valencia, Spain","volume":"19","author":"Sanf\u00e9lix-Gimeno","year":"2013","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.ejim.2017.08.011_bb0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1177\/2048872613497341","article-title":"Euro Heart Survey 2009 Snapshot: regional variations in presentation and management of patients with AMI in 47 countries","volume":"2","author":"Puymirat","year":"2013","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"key":"10.1016\/j.ejim.2017.08.011_bb0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ijcard.2005.11.018","article-title":"Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era","volume":"113","author":"Meisinger","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0050","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2796.2008.01956.x","article-title":"20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA\/KORA AMI Registry (1985\u20132004)","volume":"264","author":"Kuch","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.ejim.2017.08.011_bb0055","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S0735-1097(00)00804-4","article-title":"Myocardial infarction redefined\u2014a consensus document of the Joint European Society of Cardiology\/American College of Cardiology Committee for the Redefinition of Myocardial Infarction","volume":"36","author":"Alpert","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0060","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ypmed.2016.03.009","article-title":"Variables associated with disability in male and female long-term survivors from acute myocardial infarction. Results from the MONICA\/KORA Myocardial Infarction Registry","volume":"88","author":"Kirchberger","year":"2016","journal-title":"Prev Med"},{"issue":"27","key":"10.1016\/j.ejim.2017.08.011_bb0065","article-title":"Feasibility and psychometric properties of the German 12-item WHO Disability Assessment Schedule (WHODAS 2.0) in a population-based sample of patients with myocardial infarction from the MONICA\/KORA myocardial infarction registry","volume":"12","author":"Kirchberger","year":"2014","journal-title":"Popul Health Metrics"},{"key":"10.1016\/j.ejim.2017.08.011_bb0070","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1177\/2047487314540385","article-title":"Long-term medication adherence in patients with ST-elevation myocardial infarction and primary percutaneous coronary intervention","volume":"22","author":"Reuter","year":"2015","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2008.12.021","article-title":"Long-term medication adherence after myocardial infarction: experience of a community","volume":"122","author":"Shah","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2017.08.011_bb0080","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/fampra\/cmu042","article-title":"Repeat prescriptions of guideline-based secondary prevention medication in patients with type 2 diabetes and previous myocardial infarction in Dutch primary care","volume":"31","author":"Kasteleyn","year":"2014","journal-title":"Fam Pract"},{"key":"10.1016\/j.ejim.2017.08.011_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s40264-014-0141-3","article-title":"Self-medication with over-the-counter and prescribed drugs causing adverse-drug-reaction-related hospital admissions: results of a prospective, long-term multi-centre study","volume":"37","author":"Schmiedl","year":"2014","journal-title":"Drug Saf"},{"key":"10.1016\/j.ejim.2017.08.011_bb0090","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/ki.2015.101","article-title":"Combined use of nonsteroidal anti-inflammatory drugs with diuretics and\/or renin-angiotensin system inhibitors in the community increases the risk of acute kidney injury","volume":"88","author":"Dreischulte","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.ejim.2017.08.011_bb0095","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.h1618","article-title":"Optimal duration of dual antiplatelet therapy after percutaneous coronary intervention with drug eluting stents: meta-analysis of randomised controlled trials","volume":"350","author":"Navarese","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2017.08.011_bb0100","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ahj.2015.03.019","article-title":"Persistence with secondary prevention medications after acute myocardial infarction: insights from the TRANSLATE-ACS study","volume":"170","author":"Mathews","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ejim.2017.08.011_bb0105","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.acvd.2010.05.003","article-title":"Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization","volume":"103","author":"Tuppin","year":"2010","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2017.08.011_bb0110","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.acvd.2008.04.005","article-title":"Persistence of combination of evidence-based medical therapy in patients with acute coronary syndromes","volume":"101","author":"Amar","year":"2008","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.ejim.2017.08.011_bb0115","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40266-014-0189-x","article-title":"Secondary prevention medication after myocardial infarction: persistence in elderly people over the course of 1 year","volume":"31","author":"Al-Khadra","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.ejim.2017.08.011_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2174\/157340312801215764","article-title":"Beta blocker use after acute myocardial infarction in the patient with normal systolic function: when is it \u201cok\u201d to discontinue?","volume":"8","author":"Kezerashvili","year":"2012","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/j.ejim.2017.08.011_bb0125","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0140-6736(15)60110-6","article-title":"Effects of long-term use of cardiovascular drugs","volume":"385","author":"Julian","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.08.011_bb0130","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2340\/00015555-1760","article-title":"Angiotensin-converting enzyme inhibitor-induced angioedema\u2014a dangerous new epidemic","volume":"94","author":"Rasmussen","year":"2014","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.ejim.2017.08.011_bb0135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cpt.274","article-title":"Drug-induced diabetes mellitus: evidence for statins and other drugs affecting glucose metabolism","volume":"99","author":"Anyanwagu","year":"2016","journal-title":"Clin Pharmacol Ther"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T22:28:52Z","timestamp":1668724132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517303138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":27,"alternative-id":["S0953620517303138"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.011","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Medication use in long-term survivors from the MONICA\/KORA Myocardial Infarction Registry","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}